A hypnotic effect of chalcion (triazolam) was studied in 24 outpatients suffering from insomnia. It was found high and beneficial in pre-, intra- and post-insomniac disorders. Side effects were mild. Characteristics of chalcion-induced sleep reached to those of physiological sleep. Chalcion was found superior to other drugs used against insomnia.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[halcion triazolam
4
triazolam treatment
4
treatment insomnia]
4
insomnia] hypnotic
4
hypnotic chalcion
4
chalcion triazolam
4
triazolam studied
4
studied outpatients
4
outpatients suffering
4
suffering insomnia
4

Similar Publications

Predicting Food-Drug Interactions between Piperine and CYP3A4 Substrate Drugs Using PBPK Modeling.

Int J Mol Sci

October 2024

School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310058, China.

Piperine has been reported to inhibit the enzyme activity of cytochrome P450 (CYP) 3A4. The aim of this study was to develop and validate a physiologically based pharmacokinetic (PBPK) model for piperine and to predict potential food-drug interactions (FDIs) between piperine and CYP3A4 substrate drugs using these models. The PBPK model for piperine was successfully developed and validated.

View Article and Find Full Text PDF

Background/objectives: Index substrates are used to understand the processes involved in pharmacokinetic (PK) drug-drug interactions (DDIs). The aim of this analysis is to review metabolite measurement in clinical DDI studies, focusing on index substrates for cytochrome P450 (CYP) enzymes, including CYP1A2 (caffeine), CYP2B6 (bupropion), CYP2C8 (repaglinide), CYP2C9 ((S)-warfarin, flurbiprofen), CYP2C19 (omeprazole), CYP2D6 (desipramine, dextromethorphan, nebivolol), and CYP3A (midazolam, triazolam).

Methods: All data used in this evaluation were obtained from the Certara Drug Interaction Database.

View Article and Find Full Text PDF

PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first-pass metabolism?

CPT Pharmacometrics Syst Pharmacol

January 2025

Bayer AG, Pharmacometrics/Modeling and Simulation, Systems Pharmacology & Medicine - PBPK, Leverkusen, Germany.

Gastrointestinal first-pass metabolism plays an important role in bioavailability and in drug-drug interactions. Physiologically-based pharmacokinetic (PBPK) modeling is a powerful tool to integrate these processes mechanistically. However, a correct bottom-up prediction of GI first-pass metabolism is challenging and depends on various model parameters like the level of enzyme expression and the basolateral intestinal mucosa permeability (P).

View Article and Find Full Text PDF

The octanol/water partition coefficient, P (logP), is a hydrophobicity index and is one of the determining factors of the pharmacokinetics of chemical compounds. LogP values obtained from in silico software, open chemistry databases, and in vitro liquid chromatography retention factors may vary. Some chemicals (boscalid, etoxazole, and permethrin) have up to four-order-magnitude differences in in silico/in vitro P values.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the safety and effectiveness of performing pars plana vitrectomy (PPV) without intravenous (IV) anesthesia, focusing on patient outcomes and adverse events.
  • Conducted between September 2018 and April 2022, the study involved 357 surgeries on 319 patients, with most receiving oral sedation and a small group undergoing the procedure without any sedation.
  • Results showed significant improvement in visual acuity post-surgery and no major complications, indicating that PPV can be performed safely without an anesthesiologist, though further research is suggested to better assess patient comfort and complications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!